Umbralisib

Back to search

Molecule Structure

Scientific Name

Umbralisib

Description of the Drug

Umbralisib is a kinase inhibitor used to treat rare forms of refractory lymphoma.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB14989

Brand Name(s)

Not Available

Company Owner(s)

Tg Therapeutics Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Tyrosine-protein kinase ABL SINGLE PROTEIN INHIBITOR CHEMBL1862
Casein kinase I epsilon SINGLE PROTEIN INHIBITOR CHEMBL4937
PI3-kinase p110-delta subunit SINGLE PROTEIN INHIBITOR CHEMBL3130

Unichem Links

SureChEMBL SCHEMBL15557416
Human Metabolome Database HMDB0304848
DrugBank DB14989
PubChem 72950888
BindingDB 184556
DrugCentral 5441
ChemicalBook CB62716383
Guide to Pharmacology 8916
ZINC ZINC000141831516